US Bancorp DE increased its stake in Synopsys, Inc. (NASDAQ:SNPS - Free Report) by 0.7% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 111,418 shares of the semiconductor company's stock after purchasing an additional 788 shares during the quarter. US Bancorp DE owned approximately 0.07% of Synopsys worth $57,122,000 as of its most recent filing with the Securities and Exchange Commission.
Other institutional investors and hedge funds also recently bought and sold shares of the company. HBW Advisory Services LLC grew its stake in Synopsys by 494.9% during the 2nd quarter. HBW Advisory Services LLC now owns 3,611 shares of the semiconductor company's stock valued at $1,851,000 after acquiring an additional 3,004 shares in the last quarter. Westbourne Investments Inc. purchased a new position in Synopsys during the 2nd quarter valued at about $1,505,000. Bourgeon Capital Management LLC purchased a new position in Synopsys during the 2nd quarter valued at about $451,000. North Star Asset Management Inc. grew its stake in Synopsys by 3.6% during the 1st quarter. North Star Asset Management Inc. now owns 60,270 shares of the semiconductor company's stock valued at $25,847,000 after acquiring an additional 2,082 shares in the last quarter. Finally, SlateStone Wealth LLC grew its stake in Synopsys by 467.8% during the 1st quarter. SlateStone Wealth LLC now owns 10,220 shares of the semiconductor company's stock valued at $4,383,000 after acquiring an additional 8,420 shares in the last quarter. Hedge funds and other institutional investors own 85.47% of the company's stock.
Insiders Place Their Bets
In other Synopsys news, Director Robert G. Painter purchased 350 shares of the business's stock in a transaction dated Thursday, September 11th. The stock was bought at an average cost of $425.44 per share, for a total transaction of $148,904.00. Following the completion of the acquisition, the director directly owned 2,291 shares in the company, valued at $974,683.04. This represents a 18.03% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Sassine Ghazi sold 11,366 shares of the company's stock in a transaction that occurred on Tuesday, September 2nd. The stock was sold at an average price of $589.01, for a total value of $6,694,687.66. Following the transaction, the chief executive officer owned 71,615 shares of the company's stock, valued at approximately $42,181,951.15. This trade represents a 13.70% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 30,894 shares of company stock valued at $16,760,783 in the last three months. 0.62% of the stock is owned by corporate insiders.
Analysts Set New Price Targets
SNPS has been the topic of several research analyst reports. The Goldman Sachs Group lowered their target price on Synopsys from $700.00 to $600.00 and set a "buy" rating on the stock in a research note on Wednesday, September 10th. Citigroup cut Synopsys from a "neutral" rating to an "underperform" rating in a research note on Wednesday, September 10th. Morgan Stanley lowered their price target on Synopsys from $715.00 to $510.00 and set an "overweight" rating for the company in a research note on Thursday, September 11th. Stifel Nicolaus lowered their price target on Synopsys from $650.00 to $550.00 and set a "buy" rating for the company in a research note on Wednesday, September 10th. Finally, KeyCorp lowered their price target on Synopsys from $660.00 to $590.00 and set an "overweight" rating for the company in a research note on Wednesday, September 10th. Eleven investment analysts have rated the stock with a Buy rating, five have given a Hold rating and four have issued a Sell rating to the company's stock. Based on data from MarketBeat, the company presently has an average rating of "Hold" and a consensus price target of $575.31.
View Our Latest Report on Synopsys
Synopsys Stock Down 1.0%
SNPS opened at $484.41 on Friday. The business has a 50 day moving average price of $547.60 and a 200 day moving average price of $510.24. Synopsys, Inc. has a twelve month low of $365.74 and a twelve month high of $651.73. The company has a debt-to-equity ratio of 0.52, a quick ratio of 1.51 and a current ratio of 1.62. The firm has a market cap of $89.98 billion, a P/E ratio of 38.02, a price-to-earnings-growth ratio of 5.39 and a beta of 1.10.
Synopsys (NASDAQ:SNPS - Get Free Report) last posted its earnings results on Tuesday, September 9th. The semiconductor company reported $2.30 earnings per share for the quarter, missing the consensus estimate of $3.75 by ($1.45). Synopsys had a return on equity of 10.82% and a net margin of 31.04%.The company had revenue of $1.74 billion during the quarter, compared to analyst estimates of $1.77 billion. During the same quarter last year, the firm posted $3.43 earnings per share. The firm's revenue for the quarter was up 14.0% compared to the same quarter last year. Synopsys has set its FY 2025 guidance at 12.760-12.800 EPS. Q4 2025 guidance at 2.760-2.80 EPS. Research analysts forecast that Synopsys, Inc. will post 10.64 EPS for the current year.
Synopsys Company Profile
(
Free Report)
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
See Also
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Synopsys, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.
While Synopsys currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.